Metabolic modulation in heart failure: high time for a definitive clinical trial.
Houman
H
Ashrafian
Stefan
S
Neubauer
D000102:Acetyl-CoA C-Acyltransferase / Q000037:antagonists & inhibitors; D002908:Chronic Disease; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D006801:Humans; D015201:Meta-Analysis as Topic; D016896:Treatment Outcome; D014292:Trimetazidine / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D014665:Vasodilator Agents; D000102:Acetyl-CoA C-Acyltransferase; D014292:Trimetazidine